Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
Sales | 1,772 | 1,943 | 1,881 | 2,537 | 2,443 |
Gross Profit | 1,772 | 1,943 | 1,881 | 2,537 | 2,443 |
Operating Expenses | 15,323 | 14,482 | 14,745 | 12,637 | 13,142 |
Operating Income | -13,551 | -12,539 | -12,864 | -10,100 | -10,699 |
Interest Expense | 60 | 51 | 44 | 43 | 52 |
Other Income | 1,211 | 1,327 | 1,041 | 625 | 549 |
Pre-tax Income | -12,400 | -11,263 | -11,867 | -9,518 | -10,202 |
Net Income Continuous | -12,400 | -11,263 | -11,867 | -9,518 | -10,202 |
Net Income | $-12,451 | $-11,263 | $-11,867 | $-9,467 | $-10,202 |
EPS Basic Total Ops | -0.41 | -0.38 | -0.43 | -0.39 | -0.45 |
EPS Basic Continuous Ops | -0.41 | -0.38 | -0.43 | -0.39 | -0.45 |
EPS Diluted Total Ops | -0.41 | -0.38 | -0.43 | -0.39 | -0.45 |
EPS Diluted Continuous Ops | -0.41 | -0.38 | -0.43 | -0.39 | -0.45 |
EBITDA(a) | $-14,300 | $-12,320 | $-12,669 | $-9,911 | $-10,492 |